Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-27 Sale | 2026-03-03 4:21 pm | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 4,075 | $247.87 | $1,010,070 | 24,462 (Indirect Direct) | View |
| 2026-02-20 Sale | 2026-02-23 5:20 pm | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 1,322 | $245.66 | $324,763 | 26,238 (Indirect Direct) | View |
| 2026-02-13 Sale | 2026-02-18 9:12 pm | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 62,080 | $243.39 | $15,109,759 | 48,453 (Direct) | View |
| 2026-02-17 Sale | 2026-02-18 9:12 pm | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 89,654 | $242.8 | $21,767,827 | 181,389 (Indirect Direct) | View |
| 2026-02-17 Sale | 2026-02-18 9:12 pm | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 53,931 | $243 | $13,105,233 | 150,202 (Direct) | View |
| 2026-02-18 Sale | 2026-02-18 9:11 pm | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 22,623 | $244.33 | $5,527,506 | 68,676 (Indirect Direct) | View |
| 2026-02-17 Sale | 2026-02-18 9:11 pm | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 6,197 | $243.39 | $1,508,288 | 39,983 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-01 Tax Withholding | 2026-05-04 4:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 11,002 | $229.85 | 24,911 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 4:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 25,255 | $0 | 24,911 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:23 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 975 | $0 | 6,215 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:21 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | West Nadja Director | 975 | $0 | 7,730 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:17 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director | 975 | $0 | 12,010 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:13 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Pinto Daniel E Director | 1,712 | $0 | 2,174 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | MORIKIS JOHN G Director | 1,540 | $0 | 1,540 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director | 975 | $0 | 21,279 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Joly Hubert Director | 975 | $0 | 9,184 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 6:01 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Johnson Paula A Director | 975 | $0 | 5,359 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 5:48 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 975 | $0 | 15,488 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 5:43 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director | 975 | $0 | 10,899 (Direct) | View |
| 2026-04-23 Option Award | 2026-04-27 5:38 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director | 975 | $0 | 16,798 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 9:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 206 | $242.14 | 28,819 (Direct) | View |
| 2025-03-04 Option Award | 2026-03-12 9:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 75 | $166.1 | 28,819 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 8:39 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Pinto Daniel E Director | 129 | $242.14 | 462 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-12 8:37 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 155 | $242.14 | 5,240 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-03 4:21 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 4,075 | $115.67 | 24,462 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-03 4:21 pm | 2020-02-13 2027-02-13 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 4,075 | $0 | 24,462 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 3,690 | $244.55 | 48,453 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 523 | $243.45 | 48,453 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 73,140 | $0 | 48,453 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 22,191 | $162.75 | 48,453 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:12 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 20,846 | $0 | 48,453 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 19,368 | $165.89 | 48,453 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 20,521 | $164.62 | 48,453 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 6,631 | $244.55 | 134,691 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 635 | $243.45 | 134,691 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 15,598 | $0 | 134,691 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:12 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 18,162 | $0 | 134,691 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 1,162 | $244.55 | 43,179 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 423 | $243.45 | 43,179 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 5,006 | $0 | 43,179 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:12 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 21,781 | $0 | 43,179 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 16,455 | $244.55 | 181,389 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 1,675 | $243.45 | 181,389 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 19,241 | $115.67 | 181,389 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 12,066 | $129.51 | 181,389 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 107,784 | $0 | 181,389 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 33,386 | $131.94 | 181,389 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:12 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 57,656 | $0 | 181,389 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 866 | $244.55 | 31,054 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 189 | $243.45 | 31,054 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 3,736 | $0 | 31,054 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:12 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 5,571 | $0 | 31,054 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 913 | $243.45 | 150,202 (Direct) | View |
| 2026-02-15 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 54,844 | $0 | 150,202 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 21,721 | $157.92 | 150,202 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 9:12 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 29,927 | $156.15 | 150,202 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:12 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 52,928 | $0 | 150,202 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth EVP, Chief Legal Officer | 7,325 | $244.55 | 55,675 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth EVP, Chief Legal Officer | 1,036 | $243.45 | 55,675 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth EVP, Chief Legal Officer | 16,381 | $0 | 55,675 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:11 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth EVP, Chief Legal Officer | 29,020 | $0 | 55,675 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 13,956 | $244.55 | 258,546 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 1,761 | $243.45 | 258,546 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 32,155 | $0 | 258,546 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:11 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 58,809 | $0 | 258,546 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 1,824 | $244.55 | 68,676 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 463 | $243.45 | 68,676 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 13,625 | $115.67 | 68,676 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 8,998 | $129.51 | 68,676 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 29,554 | $0 | 68,676 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:11 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 38,037 | $0 | 68,676 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 32,668 | $244.55 | 510,180 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 3,562 | $243.45 | 510,180 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 84,710 | $0 | 510,180 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:11 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 141,193 | $0 | 510,180 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 3,892 | $244.55 | 39,983 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 522 | $243.45 | 39,983 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 9:11 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 10,020 | $0 | 39,983 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 9:11 pm | N/A 2036-02-15 | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 15,439 | $0 | 39,983 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:47 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 37,463 | $0 | 37,463 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:45 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 27,412 | $0 | 27,412 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:43 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 9,412 | $0 | 9,412 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:41 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 4,378 | $0 | 4,378 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:39 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 3,602 | $0 | 3,602 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:37 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth EVP, Chief Legal Officer | 13,706 | $0 | 13,706 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:34 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 73,054 | $0 | 73,054 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:33 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 2,741 | $0 | 2,741 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:28 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 13,706 | $0 | 13,706 (Direct) | View |
| 2026-02-09 Option Award | 2026-02-11 8:24 pm | 2026-02-13 N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 8,594 | $0 | 8,594 (Direct) | View |
| 2026-02-06 Exercise | 2026-02-10 9:46 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 15,571 | $101.87 | 22,916 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 9:46 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 10,335 | $239.99 | 22,916 (Direct) | View |
| 2026-02-06 Exercise | 2026-02-09 7:42 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 5,625 | $101.87 | 16,409 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-09 7:42 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 3,335 | $239.99 | 16,409 (Direct) | View |